Clinical Trials Logo

Retinal Perforations clinical trials

View clinical trials related to Retinal Perforations.

Filter by:

NCT ID: NCT01229657 Completed - Macular Holes Clinical Trials

Evaluation of Anatomic and Visual Outcomes of Initially Closed Macular Holes

Start date: March 2010
Phase: N/A
Study type: Observational

To evaluate the anatomic and visual outcomes in patients with initially closed macular holes after vitreoretinal surgery and with one to seven years of follow-up.

NCT ID: NCT01226160 Completed - Clinical trials for Full Thickness Macular Hole

Pilot Randomised Controlled Trial of Posturing Following Surgery for Full-thickness Macular Hole

Start date: January 2005
Phase: Phase 0
Study type: Interventional

This is a pilot randomised controlled trial (RCT) to investigate the effect of postoperative face-down positioning on the outcome of macular hole surgery.

NCT ID: NCT01069029 Completed - Visual Acuity Clinical Trials

Combined Versus Successive Macular Hole and Cataract Surgery

Start date: January 2006
Phase: N/A
Study type: Observational

The purpose of this study is to compare functional and anatomical results of a combined surgery and two time surgery for macular hole and cataract extraction in one hundred and twenty patients (120 eyes) with idiopathic Macular Hole (MH) and cataract in two academic centers.

NCT ID: NCT01020760 Completed - Clinical trials for Full Thickness Macular Hole

Protocol for RCT of Posturing in Phacovitrectomy for Full Thickness Macular Hole (FTMH)

Start date: September 2008
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effect of postoperative posturing on the outcome of macular hole surgery. Current practice is divided; some individuals are advised to posture face-down for 10 days and others are advised that posturing is unnecessary. By evaluating the effect of posturing in a prospective randomised controlled trial the investigators hope to determine best practice, enabling surgeons and patients to make informed decisions regarding postoperative management.

NCT ID: NCT00941291 Completed - Clinical trials for Idiopathic Macular Hole

Outcome of Idiopathic Macular Hole

Start date: January 2002
Phase: N/A
Study type: Observational

The purpose of this study is to evaluate the role of cataract surgery and cystoid macular edema (CME) on reopening of idiopathic macular holes (IMH).

NCT ID: NCT00757471 Completed - Clinical trials for Idiopathic Macular Holes

Brillant Blue Versus Indocyanine Green for Macular Hole Surgery

Start date: August 2008
Phase: N/A
Study type: Interventional

Macular Hole Surgery with two different Dyes

NCT ID: NCT00737074 Completed - Clinical trials for Proliferative Diabetic Retinopathy

Macular Hole in Diabetic Retinopathy

Start date: January 2002
Phase: N/A
Study type: Observational

Macular hole in proliferative diabetic retinopathy with fibrovascular proliferation may have unique features. Internal limiting membrane peeling facilitates hole closure only in cases with shallow macular detachment. Final vision is associated with preoperative visual acuity and degree of macula elevation.

NCT ID: NCT00419185 Completed - Clinical trials for Idiopathic Macular Hole

Indocyanine Green or Trypan Blue for Delamination of the Internal Limiting Membrane in Macular Hole Surgery

Start date: April 2003
Phase: N/A
Study type: Interventional

To evaluate the anatomical and visual outcomes after vitrectomy and internal limiting membrane (ILM) peeling with indocyanine green (ICG) or trypan blue (TB) for idiopathic macular hole repair in a prospective randomized trial.

NCT ID: NCT00302328 Completed - Clinical trials for Idiopathic Macular Hole

Trial of Prognostic Factors and Surgical Methods for the Treatment of Idiopathic Macular Holes

Start date: August 2005
Phase: N/A
Study type: Interventional

The project is a randomized clinical trial with a follow up time of 12 months comparing the effects of surgical treatment of idiopathic macular holes. Patients are randomized to vitrectomy alone, vitrectomy plus indocyanine green (ICG) assisted inner limiting membrane ( ILM) peeling or vitrectomy plus trypan blue (tb) assisted ILM peeling. At baseline patients are characterized using early treatment diabetic retinopathy study (ETDRS) visual charts, tests of aniseikonia, optical coherence tomography 3 (OCT3), visual field and fundus photography. Per- and postoperative complications are registered. Data analyses will help clarify the effect of ILM peeling on hole closure and visual acuity. Comparing results after ICG- and tb assisted ILM peeling will help clarify the topic of a toxic effect on retinal cells after staining and peeling of the ILM. Changes in intraretinal morphology before and after dye-assisted ILM peeling will be studied using OCT3 imaging and the patients' subjective opinion on the surgical results will be analyzed using quality of life questionnaires and metamorphopsia tests.

NCT ID: NCT00286507 Completed - Clinical trials for Stage 2 or 3 Full Thickness Macular Hole

Full Thickness Macular Hole and Internal Limiting Membrane Peeling Study

FILMS
Start date: July 2005
Phase: N/A
Study type: Interventional

A macular hole is a fairly common problem in the retina and is an important cause of loss of central vision. The aim of this study is to determine whether, in patients with a stage 2 or 3 full thickness macular hole (FTMH), peeling a very fine, transparent tissue that covers the surface of the retina, called the internal limiting membrane (ILM) during surgery is superior to non-ILM peeling macular hole surgery. The main outcomes are improvement in vision, achievement of macular hole closure, need for re-operation, health related quality of life (HRQOL) and cost effectiveness.